Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua D Palmer

Showing results (1-10 of 233) with videos related to

Pageof 24
Sort By:
Chinese Clinical Oncology|August 27, 2017
PrefaceWenyin Shi, Joshua D Palmer
International Journal of Radiation Oncology, Biology, Physics|May 17, 2025
INDI-NO-GO: A Recommendation for Caution with Use of Isocitrate Dehydrogenase Inhibitors for High-Risk, Low-Grade GliomasRaj Singh, Joshua D Palmer
International Journal of Radiation Oncology, Biology, Physics|February 23, 2025
Do Not Be Shy When It Comes to the Spine: The Importance of Craniospinal Irradiation in High-risk EpendymomaRaj Singh, Joshua D Palmer
Annals of Translational Medicine|August 6, 2015
Targeted drug combinations: avant-garde oncologyTu D Dan, Joshua D Palmer
Chinese Clinical Oncology|January 22, 2024
Emerging insights on management of high-grade gliomaWenyin Shi, Joshua D Palmer, Iyad Alnahhas
Cancer|April 7, 2023
Reply to "Is the hippocampus-sparing attempt really reasonable within the current technological possibilities?"Sujith Baliga, Joshua D Palmer, Torunn I Yock
Advances in Radiation Oncology|March 14, 2022
COVID-19 Booster Vaccine Equity for Patients With CancerRahul N Prasad, Manali Patel, Joshua D Palmer
JCO Oncology Practice|January 24, 2022
Do Federal Price Transparency Regulations Neglect Oncology Patients?Rahul N Prasad, Trevor J Royce, Joshua D Palmer
JAMA Oncology|June 23, 2018
The Urgent Need in Oncology for a Comprehensive Cost of Care Task ForceJoshua D Palmer, Tejash T Patel, Scot A Fisher
American Journal of Clinical Oncology|December 16, 2014
Lymph Node Burden as a Predictive Factor for Selective Chemoradiotherapy in Patients With Locally Advanced Gastric Cancer After a D2 Dissection: A Retrospective StudyQiwen Li, Guichao Li, Joshua D Palmer, et al.
Pageof 24

Showing results (1-10 of 233) with videos related to

Sort By:
Pageof 24
Chinese Clinical Oncology|August 27, 2017
PrefaceWenyin Shi, Joshua D Palmer
International Journal of Radiation Oncology, Biology, Physics|May 17, 2025
INDI-NO-GO: A Recommendation for Caution with Use of Isocitrate Dehydrogenase Inhibitors for High-Risk, Low-Grade GliomasRaj Singh, Joshua D Palmer
International Journal of Radiation Oncology, Biology, Physics|February 23, 2025
Do Not Be Shy When It Comes to the Spine: The Importance of Craniospinal Irradiation in High-risk EpendymomaRaj Singh, Joshua D Palmer
Annals of Translational Medicine|August 6, 2015
Targeted drug combinations: avant-garde oncologyTu D Dan, Joshua D Palmer
Chinese Clinical Oncology|January 22, 2024
Emerging insights on management of high-grade gliomaWenyin Shi, Joshua D Palmer, Iyad Alnahhas
Cancer|April 7, 2023
Reply to "Is the hippocampus-sparing attempt really reasonable within the current technological possibilities?"Sujith Baliga, Joshua D Palmer, Torunn I Yock
Advances in Radiation Oncology|March 14, 2022
COVID-19 Booster Vaccine Equity for Patients With CancerRahul N Prasad, Manali Patel, Joshua D Palmer
JCO Oncology Practice|January 24, 2022
Do Federal Price Transparency Regulations Neglect Oncology Patients?Rahul N Prasad, Trevor J Royce, Joshua D Palmer
JAMA Oncology|June 23, 2018
The Urgent Need in Oncology for a Comprehensive Cost of Care Task ForceJoshua D Palmer, Tejash T Patel, Scot A Fisher
American Journal of Clinical Oncology|December 16, 2014
Lymph Node Burden as a Predictive Factor for Selective Chemoradiotherapy in Patients With Locally Advanced Gastric Cancer After a D2 Dissection: A Retrospective StudyQiwen Li, Guichao Li, Joshua D Palmer, et al.
Pageof 24